Abbreviations
| Abbreviation | Full Form | Meaning | Usage Example | Context |
|---|---|---|---|---|
VLP | Virus-Like Particle | A particle composed of viral structural proteins that resembles a virus but lacks its complete infectious genome. | VLP technology is used in several vaccine platforms. | Vaccine platform |
mRNA | Messenger Ribonucleic Acid | A nucleic acid molecule used in some vaccines to provide cells with temporary instructions for producing a selected antigen. | An mRNA vaccine delivers genetic instructions for antigen production. | Nucleic acid vaccines |
DNA vaccine | Deoxyribonucleic Acid Vaccine | A vaccine platform that uses DNA encoding an antigen to stimulate an immune response. | DNA vaccine research examines immune responses generated against an encoded antigen. | Genetic vaccine platforms |
AdV | Adenoviral Vector | A modified adenovirus-based delivery platform used to carry genetic instructions for an antigen in certain vaccines. | An AdV platform can deliver an antigen-encoding sequence to host cells. | Viral-vector vaccines |
LNP | Lipid Nanoparticle | A nanoscale lipid-based carrier used to protect and deliver nucleic acids in some vaccine formulations. | LNPs are used to deliver mRNA in several vaccine platforms. | Vaccine delivery systems |
AS | Adjuvant System | A formulation containing one or more components designed to enhance or shape the immune response to a vaccine antigen. | An AS can improve the magnitude or quality of an immune response. | Vaccine formulation |
GMT | Geometric Mean Titer | A statistical measure commonly used to summarize antibody titers across a group of individuals. | The GMT was reported to summarize antibody responses after vaccination. | Immunogenicity measurement |
PRNT | Plaque Reduction Neutralization Test | A laboratory assay used to measure the ability of antibodies to reduce viral plaque formation in a cell-based system. | PRNT results were used to evaluate neutralizing antibody activity. | Neutralizing antibody assessment |
AEFI | Adverse Event Following Immunization | Any unfavorable medical occurrence following immunization, whether or not it is causally related to the vaccine. | An AEFI report records a medical event occurring after immunization. | Vaccine safety monitoring |
EPI | Expanded Programme on Immunization | A public-health program framework established by the World Health Organization to improve access to essential vaccines. | National EPI programs organize routine vaccination services. | Public-health immunization |